Sphere Medical Share Discussion Threads

[waterloo01] 10/2/2017 14:02

Trouble is does anyone still think this has enough mass to achieve the sales and crucially profit to make it worthwhile as a stand alone company and if not, it would be very much in shareholders interests to sell the whole thing to a larger player (as was the original intention). Trouble is the boys in charge will want to keep their jobs!

[del44] 10/2/2017 14:00

I think a new funding round is a nailed on certanty!!!

[yasx] 09/2/2017 23:35

It is an interesting company, but, at this stage, nothing more. It is far easier to wait and see evidence of a turn before wading in, rather than tucking in now in anticipation of sales traction.

Given the cash burn, a placing this year is not inconceivable but probable.

[del44] 09/2/2017 15:12

The cash burn is roughly £475K per month down significantly with the fall of R&D on Proxima. They carry as much as a tax credit going forward.
I calculate they have about enough money to keep going until about July...not withstanding the £1.5M loan from SVB...the other part of the draw down is conditional....perhaps on sales..
The loan is on an annual 7% gross payment.
SVB must have seen something they like......the P3 was never going to get traction on sales but was for valuble feed back which was incorporated into the P4 system.
Funding will be needed, however which way they go about it......I would imagine that the FY figures will cast more light on the present situation....
I agree the pay structure is very high indeed for a company not producing any sales at the moment...

[woodcutter] 09/2/2017 13:49

Spent a few hours researching this morning and i think prox4 has legs but i can be patient so need to see some sales first. If it was so good i'd have expected prox3 to have delivered better sales volumes.

As always with these pharma loss making co's i tend to look at the directors emoluments which was a further reason for holding back on any investment. In 2015 Rencken in total paid himself £388K including a performance bonus of £124K. This was up from a total of £260K in 2014. The total cost of the board in 2015 was £799K. Hard to see why the performance related pay was given, perhaps it was to offset all the options he and others are holding as they now look worthless.

The operating expenses were around £6m+. Notwithstanding is seems historically the case with loss making pharma's there are too many Dr's/consultants with their noses in the trough. They're carrying far to many exec and non exec directors for no or very little revenue imv.

on my watch list but it needs to prove it can make significant sales

woody

post note: perhaps woodford and his chums will find a way to take it private

[cumnor] 09/2/2017 10:15

Muppet, try and do a bit of proper research and stop bulls...ting. Your 6p short already dead in the water?

[longshanks] 09/2/2017 10:11

The problem is:June 2015: cash £12mJune 2016: cash £6.6mHeavily dilutive fundraising at 5p is in the offing IMO - so this can't bounce like it wants to because some shysters are forward selling.

[someuwin] 09/2/2017 10:08

Bouncing strongly.

[longshanks] 09/2/2017 09:53

29 April 2015: £13.2m raised09 February 2017: £9.4m market capSome imbalance here caused by RLAM dumping its entire holding onto an illiquid market and no-one seeing fit to notify us. Price will bounce - hence why you are here someuwin.They probably don't have much left from the £13.2m raised. They spend like they are Siemens - but don't habe the income/cash flow to sustain it. More cash will be needed - maybe why RLAM baled.Come on Wolfie, get your act together.

[someuwin] 09/2/2017 09:05

Some buying interest today.

[timbo003] 08/2/2017 13:21

Thanks Aim-trader, I have already booked my place.

[aim_trader] 08/2/2017 13:03

Richard Wright, CFO, Will be presenting to investors at the Biotech Capital Conference on 21st February. For more details and registration, click here:

[longshanks] 03/2/2017 14:11

A bit optimistic there I fancy.Certainly the broker that took on the job of disposing RLAM's load would appear to have done pretty well and at a decent profit.However the likelihood is that those new homes are not too permanent: so a return to 10p could take some time if there is no impetus for investors to value the stock higher.Still I am confident that Wolfie and his team will do the business this year and start getting some serious traction. At least, here's hoping!

[cc2014] 03/2/2017 12:57

I'm guessing but it looks like the market has now completely absorbed the RLAM sale. Certainly if you look at the flow of trade it won't make any difference or not whether Peel have a few hundred thousand left or not as they will be gobbled up soon.

It's to see this rising for a change

[longshanks] 03/2/2017 08:25

I have been "filling my boots". Should be a good gamble so long as other IIs aren't planning their own exit.Woodford are fully loaded (at 30%) - so can't feast on the carcass of RLAM's offload - but I am sure others are...

[cc2014] 03/2/2017 07:35

Today should be interesting. It seems reasonable to suggest that the buying that kicked off yesterday afternoon will continue this morning.Have we seen the classic turn off high volume resulting in a sustained rise in the share price?

[del44] 02/2/2017 15:21

Lots of buying.....

[del44] 02/2/2017 13:42

Cheers for that....

[cc2014] 02/2/2017 08:55

It was RLAM. Expect to see an RNS in the next couple of days. They've sold everything they had so hopefully price should bounce now as the overhang clears

[longshanks] 02/2/2017 02:45

I doubt there is anything fishy: more likely an II has decided to exit and book the "loss" to offset profits elsewhere.My guess it is either Octopus or RLAM: we should find out in the next day or so.It does appear to present a good buying opportunity IMO.

[del44] 01/2/2017 17:37

4,824,185 @ 5p on 30 January...is the reason for our 30% fall...
Take your pick as to who it was......big discount to the market at the time...
Question is....why?

[tini5] 31/1/2017 23:33

Most insightful CC, thanks for sharing!

The game's afoot!